Literature DB >> 22116676

Characteristics of children with sporadic hemolytic uremic syndrome in a single Northern California center.

Gia Oh1, Keith K Lau.   

Abstract

PURPOSE: Hemolytic uremic syndrome (HUS) is a frequent cause of acute kidney injury in children. The aim of this study is to describe our experience at a Northern California center.
METHODS: Medical records of children suffered from HUS (08/99 to 03/09) at University of California Davis Medical Center were reviewed.
RESULTS: Forty-six children (70% girls) were studied, and their median age was 3.5 years. Diarrhea was a presenting symptom in 42 subjects (91%), and hematochezia was present in 31 children (67%). Escherichia coli 0157:H7 was isolated in 20 patients (44%). Thirteen subjects (28%) underwent dialysis for a median of 7 days during their hospitalization. Follow-up was achieved in 36 patients (78.3%) for a median of 16 months. One patient required angiotensin-converting enzyme (ACE) inhibitor for proteinuria but none was on dialysis.
CONCLUSIONS: In our cohort in children with HUS in a single Californian center, long-term complications were uncommon during a median follow-up time of 16 months.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22116676     DOI: 10.1007/s11255-011-0083-y

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  24 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings.

Authors:  N Banatvala; P M Griffin; K D Greene; T J Barrett; W F Bibb; J H Green; J G Wells
Journal:  J Infect Dis       Date:  2001-03-01       Impact factor: 5.226

3.  The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota.

Authors:  D L Martin; K L MacDonald; K E White; J T Soler; M T Osterholm
Journal:  N Engl J Med       Date:  1990-10-25       Impact factor: 91.245

4.  Streptococcus pneumoniae--associated hemolytic uremic syndrome: classification and the emergence of serotype 19A.

Authors:  Lawrence Copelovitch; Bernard S Kaplan
Journal:  Pediatrics       Date:  2009-12-21       Impact factor: 7.124

5.  Population-based trends in pediatric hemolytic uremic syndrome in California, 1994-1999: substantial underreporting and public health implications.

Authors:  Kate C Cummings; Janet C Mohle-Boetani; S Benson Werner; Duc J Vugia
Journal:  Am J Epidemiol       Date:  2002-05-15       Impact factor: 4.897

Review 6.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Authors:  Phillip I Tarr; Carrie A Gordon; Wayne L Chandler
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

7.  Atypical hemolytic uremic syndrome in the Tunisian population.

Authors:  Nadia Leban; Sabra Aloui; Dalel Touati; Ramzy Lakhdhar; Habib Skhiri; Gerard Lefranc; Abdellatif Achour; Mezri Elmay; Margarita Lopez-Trascasa; Pilar Sanchez-Corral; Jemni Chibani; Amel Haj Khelil
Journal:  Int Urol Nephrol       Date:  2010-05-25       Impact factor: 2.370

8.  National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification.

Authors:  Ronald J Hogg; Susan Furth; Kevin V Lemley; Ronald Portman; George J Schwartz; Josef Coresh; Ethan Balk; Joseph Lau; Adeera Levin; Annamaria T Kausz; Garabed Eknoyan; Andrew S Levey
Journal:  Pediatrics       Date:  2003-06       Impact factor: 7.124

9.  Hemolytic uremic syndrome epidemiology: a population-based study in King County, Washington, 1971 to 1980.

Authors:  P I Tarr; R O Hickman
Journal:  Pediatrics       Date:  1987-07       Impact factor: 7.124

10.  Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype.

Authors:  J G Wells; B R Davis; I K Wachsmuth; L W Riley; R S Remis; R Sokolow; G K Morris
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

View more
  4 in total

1.  Early erythropoietin in post-diarrheal hemolytic uremic syndrome: a case-control study.

Authors:  Alejandro Balestracci; Sandra Mariel Martin; Ismael Toledo; Caupolican Alvarado; Raquel Eva Wainsztein
Journal:  Pediatr Nephrol       Date:  2014-08-21       Impact factor: 3.714

2.  Erythropoietin in children with hemolytic uremic syndrome: a pilot randomized controlled trial.

Authors:  Alejandro Balestracci; Marina Andrea Capone; Luciana Meni Battaglia; Ismael Toledo; Sandra Mariel Martin; Laura Beaudoin; Jeanette Balbaryski; Lorena Gómez
Journal:  Pediatr Nephrol       Date:  2022-02-15       Impact factor: 3.651

3.  Impact of platelet transfusions in children with post-diarrheal hemolytic uremic syndrome.

Authors:  Alejandro Balestracci; Sandra Mariel Martin; Ismael Toledo; Caupolican Alvarado; Raquel Eva Wainsztein
Journal:  Pediatr Nephrol       Date:  2013-02-06       Impact factor: 3.714

4.  Renal replacement therapy in adult and pediatric intensive care : Recommendations by an expert panel from the French Intensive Care Society (SRLF) with the French Society of Anesthesia Intensive Care (SFAR) French Group for Pediatric Intensive Care Emergencies (GFRUP) the French Dialysis Society (SFD).

Authors:  Christophe Vinsonneau; Emma Allain-Launay; Clarisse Blayau; Michael Darmon; Damien Ducheyron; Theophile Gaillot; Patrick M Honore; Etienne Javouhey; Thierry Krummel; Annie Lahoche; Serge Letacon; Matthieu Legrand; Mehran Monchi; Christophe Ridel; René Robert; Frederique Schortgen; Bertrand Souweine; Patrick Vaillant; Lionel Velly; David Osman; Ly Van Vong
Journal:  Ann Intensive Care       Date:  2015-12-30       Impact factor: 6.925

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.